Abdel-Motaal Fouda

Prof. Abdel-Motaal Fouda


Research Focus & Metrics

Academic Career Length

24Years (2003-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
12 December 2003 in Journal of Gastroenterology and Hepatology
Verified
Journal Article
Closed access
PDF file
GDGamal M Dahab
Gamal M Dahab
MKMohamed M Kheriza
Mohamed M Kheriza
HEHussien M El‐Beltagi
Hussien M El‐Beltagi
AFAbdel-Motaal Fouda
Abdel-Motaal Fouda
OEOsama A Sharaf El‐Din
Osama A Sharaf El‐Din

19 July 2008 in Basic & Clinical Pharmacology & Toxicology
Verified
Journal Article
Closed access
PDF file
AFAbdel-Motaal Fouda
Abdel-Motaal Fouda
MDMohamad‐Hesham Y. Daba
Mohamad‐Hesham Y. Daba
GDGamal M. Dahab
Gamal M. Dahab
OEOsama A. Sharaf El‐Din
Osama A. Sharaf El‐Din

12 February 2009 in Basic & Clinical Pharmacology & Toxicology
Verified
Journal Article
Closed access
PDF file
AFAbdel-Motaal Fouda
Abdel-Motaal Fouda
MBMohamed Y. Berika
Mohamed Y. Berika

1 October 2007 in Canadian Journal of Physiology and Pharmacology
Verified
Journal Article
Closed access
AFAbdel-Motaal Fouda
Abdel-Motaal Fouda
MDMohamad-Hesham Y. Daba
Mohamad-Hesham Y. Daba
GDGamal M. Dahab
Gamal M. Dahab
We examined an aqueous extract of Hibiscus sabdariffa calyces extracts (HSE) by close-arterial injection on micturition thresholds (MTs) and on uterine contractions (rate and amplitude). Five doses of HSE were examined (1, 5, 10, 50, and 100 mg/kg) in 3 groups of rats: controls, after bladder inflammation, and after bilateral hypogastric neurectomy. In some rats, uterine contractions were induced by injection of oxytocin (OT) and the effect of HSE was compared with that of nifedipine. HSE increased MTs in a dose-dependent manner in all groups. Neither atropine (0.1 mg/kg) nor propranolol (0.4 mg/kg) had significant effects on cystometric parameters. They also did not affect the responses obtained by HSE on cystometric parameters. As with bladder response, HSE inhibited both the rate and amplitude of uterine contractions in all groups in a dose-dependent manner. The uterine response to HSE was not affected by administration of either atropine or propranolol. A slight, but significant, reduction of contraction amplitude by HSE in the OT precontracted uteri was only noted at a dose of 500 mg/kg. Nifedipine was more potent than HSE in reducing uterine contraction amplitude. The present work documents inhibition by HSE of the rat bladder and uterine contractility in a dose-dependent manner via a mechanism unrelated to local or remote autonomic receptors or calcium channels. However, further investigation is needed to establish the exact mechanism of action.

29 July 2017 in Osteoporosis and Sarcopenia
Verified
Journal Article
Open access
AFAbdel-Motaal Fouda
Abdel-Motaal Fouda
AYAmany Ragab Youssef
Amany Ragab Youssef
Objectives: The effect of Salvadora persica sticks on prevention of tooth decay is well established, but the effect of S. persica stick extract (SPE) on the prevention/treatment of osteoporosis has not been studied. The purpose of this study is to provide baseline information of the effectiveness of SPE on ovariectomized (OVX) rat model of osteoporosis. Methods: SPE was administered at 50, 150, and 300 mg/d orally to OVX rats for 16 weeks. Serum osteocalcin, alkaline phosphatase, calcium, and phosphorus, and urinary deoxypyridinoline, calcium, and phosphorus were measured. Bone mineral density (BMD), 3-point bending test, and histomorphometric characteristics of the femoral bone were also examined. Results: SPE at doses of 150 and 300 mg/d, but not 50 mg/d, significantly prevented bone loss in OVX rats as proved by decreased biochemical markers of bone resorption and increased BMD and biomechanical indices of the femoral bone. Conclusions: This study confirms a dose-dependent protective action of SPE on rat OVX model of osteoporosis. This effect needs further investigation at the molecular and clinical levels to provide a natural and cost-effective alternative for the management of postmenopausal osteoporosis.

19 March 2018 in Cancer Drug Resistance
Verified
Journal Article
Open access
OEOsama Sharaf Eldin
Osama Sharaf Eldin
AFAbdel-Motaal Fouda
Abdel-Motaal Fouda
AYAmany R. Youssef
Amany R. Youssef
PHPeter Hamilton
Peter Hamilton
PMPerry Maxwell
Perry Maxwell
KWKate E. Williamson
Kate E. Williamson
Cancer Drug Resistance is journal focuses on pharmacological aspects of drug resistance and its reversal, including molecular mechanisms of drug resistance and drug classes.